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Objectives: Depression occurs commonly among patients with COPD, but the independent
association of depression and COPD and the effect of depression on COPD outcomes are not
well established.
Method: A population sample of 2402 Chinese aged 55 with and without COPD
(characteristic symptoms of chronic cough, sputum or breathlessness and airflow
obstruction and FEV1/FVC< 0.70) was assessed on Geriatric Depression Scale (score 5),
dependence on basic activities of daily living (ADL), SF-12 health status, smoking and
medication behaviour.
Results: The 189 respondents with COPD showed higher depressive symptoms prevalence
(22.8%) than 2213 respondents without COPD (12.4%); multivariate odd ratio (OR) was 1.86;
95% CI, 1.25e2.75 after controlling for confounding risk factors. In multivariate analyses of
respondents with COPD, those who were depressed (NZ 43), compared to those who were
not (NZ 146), were more likely to report ADL disability (ORZ 2.89, pZ 0.049) poor or fair
self-reported health (ORZ 3.35, pZ 0.004), poor SF-12 PCS scores (ORZ 2.35, pZ 0.041)
and SF-12 MCS scores (ORZ 4.17, p< 0.001).
Conclusion: Depressive symptoms were associated with COPD independent of known risk
factors. In COPD participants, depressive symptoms were associated with worse health and
functional status and self-management.
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Chronicobstructivepulmonarydisease(COPD) isamajorcause
of disability and death worldwide.1 In contrast to the marked
morbidity and mortality declines observed with other major
chronicdiseases, the trends forchronicobstructivepulmonary
disease (International Classification of Diseases, Tenth Revi-
sion, ICD-10J40-J47)arecontinually increasing.2Patientswith
COPD bear a heavy burden of respiratory distress, physical
disability in daily living activities and poor quality of life.
Depression is commonly observed in patients with COPD.
Reports suggest that depressive disorders or depressive
symptoms are present in between 16 and 74% of patients
with COPD.3e7 However, depression is also present in
significant proportions of elderly in the community without
COPD, and known risk factors for depression that are
common in the elderly such as psychosocial deprivation and
loss, multiple chronic illnesses, poor health and functional
disability and the use of multiple drugs that potentially can
cause depression could all contribute to increase the
prevalence of depression in COPD patients. Hence, the
primary co-morbid association of depression and COPD
resulting uniquely from psychobiological processes specifi-
cally related to COPD, without the mediating effects of
other risk factors, is debatable. Systematic reviews8 have
highlighted the major methodological drawbacks in
previous studies that investigated this relationship. These
included lack of control groups, small sample sizes, highly
selective patient samples in clinical settings, failure to take
into account important confounding by psychosocial and
socio-economic factors, medical co-morbidity, and medi-
cations which cause mood alterations.
Furthermore, few studies have demonstrated whether
the presence of depression among the elderly with COPD
had a strong adverse effect on COPD-specific outcomes,
medication adherence and smoking cessation, poorer func-
tional status and quality of life. The Medical Outcomes Study
suggested that patients with chronic respiratory disease
(next only to patients with chronic gastro-intestinal disease)
appeared worst off on their mental health status than
patients with all other chronic diseases.9 Whereas studies
of patients with coronary artery disease, diabetes and
hypertension have demonstrated that depression is asso-
ciated with major adverse impact on specific disease
outcomes,10e13 very few studies have evaluated the impact
of depression on disease specific outcomes in COPD patients.
In this population-based study of Chinese older adults
aged 55 and above, we sought to determine whether
depressive symptoms were associated with COPD indepen-
dent of other known risk factors and health correlates; and
among those with COPD, whether depressed respondents
were more likely to experience worse health, functional and
quality of life status, and performance on self-management
tasks related to medication and smoking behavior.
Method
Study population
The study was based on baseline data collected from the
Singapore Longitudinal Ageing Study (SLAS) of ageing andhealth.14 The SLAS is an ongoing observational cohort study
of a whole population of community-dwelling Singaporean
older adults resident in five districts in South East Region
of Singapore. Singaporean citizens or permanent residents
aged 55 and above were identified by door-to-door census,
and invited to participate. Residents who were physically
or mentally incapacitated to give informed consent or
participate were excluded. A total of 2804 residents
participated in the study (estimated response rate 78%).
The study was approved by the National University of
Singapore Institutional Review Board.
Spirometry
Ventilatory function testing was performed using
a portable, battery operated, ultrasound transit-time based
spirometer (Easy-One; Model 2001 Diagnostic Spirometer,
NDD Medical Technologies, Zurich, Switzerland). Calibra-
tion was checked daily with a 3-L syringe. Forced expiratory
maneuvers were performed with the respondent seated
according to American Thoracic Society (ATS) recom-
mended guidelines and standardization of procedures: at
least three acceptable maneuvers, with forced vital
capacity (FVC) and forced expiratory volume in the first
second (FEV1) reproducible within 200 mL. Chronic airflow
obstruction was defined as FEV1/FVC< 0.70.
Height and weight were measured with a portable Seca
stadiometer (Model 708 1314004, Vogel & Hake Hamburg,
Germany)
Questions from the British Medical Research Council
Questionnaire on chronic respiratory symptoms were used
to elicit symptoms characteristic of COPD: chronic cough
and/or sputum lasting at least 3 months in the year and/or
breathlessness on exertion.
COPD
Among the 2478 Chinese respondents in the cohort, 81
respondents who did not perform spirometry, 46 respondents
with technically unsatisfactory spirometric performance and
3 with other missing data were excluded. We identified cases
of COPD among the participants who had characteristic
symptoms of COPD and spirometric evidence of chronic
airflow obstruction (FEV1/FVC< 0.70), consistent with the
definition as proposed by the Global Initiative for Chronic
Obstructive Lung Disease (GOLD).15 Because it is difficult to
differentiate COPD and asthma in some individuals, we
excluded respondents (NZ 76) who reported a history of
asthma diagnosis and treatment (40 among those with airflow
obstruction, and 36 among those without). The final analysis
was therefore based on 2402 respondents.
Among the resulting 189 respondents with COPD,
severity of airflow obstruction was assessed using FEV1
percent of predicted values for normal lung function
derived from the data from the present study, according to
GOLD recommended criteria: mild: FEV1 80% of pre-
dicted, moderate: FEV1 50% or more and less than 80%
predicted, severe: FEV1< 50% of predicted.
Depression
The presence of depressive symptoms was determined by
the 15-item Geriatric Depression Scale (GDS-15).16,17 It is
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the measurement artefact due to overlapping somatic
symptoms of physical illness(es) and depression. The
translated versions of the GDS have been found to have good
reliability (coefficient of 0.90), sensitivity (96.3%) and
specificity (87.5%) for assessing late-life depression in
Chinese subjects.18 The internal reliability coefficient
(Cronbach’s a) was 0.84. Scores range from 0 to 15, and
scores of 5 or more are indicative of depression. Face-to-
face interviews were performed using both English and
Chinese versions of the GDS, according to the respondents’
language preference.
Other measurements
Co-morbid medical illnesses
Respondents were asked to report whether in the 12
months prior to the interview they were diagnosed and
treated by a doctor for any one or more of 16 specific
medical conditions, which included asthma, COPD, coronary
artery disease, heart failure, hypertension, dyslipidemia,
diabetes, stroke, hip fracture, arthritis, asthma, COPD,
cataract, and other conditions specified by them. The
presence of hypertension was defined by a self-report
of high blood pressure, and/or treatment with anti-
hypertensive drugs and/or sitting systolic blood pressure
140 mm Hg and/or sitting diastolic blood pressure90 mm
Hg. The presence of diabetes was defined as self-report
of diabetes and/or treatment with oral hypoglycemic agents
or insulin, and/or fasting blood glucose >7.0 mmol/L.
Hyperlipidemia was defined as self reported hyperlipidemia,
and/or total cholesterol 6.5 mmol/L and/or LDL-
Cholesterol 4.1 mmol/L and/or TG 2.3 mmol/L and/or
HDL-Cholesterol <1.0 mmol/L and/or total cholesterol:
HDL-Cholesterol ratio >4.5.
Potentially depressogenic medications
For each medical condition reported by the respondent,
information on the drugs currently used was ascer-
tained from the drug labels physically produced by the
respondents. This included the use of drugs widely reported
in the literature to cause depression: corticosteroids
(e.g. prednisolone), hormone replacement therapy (e.g.
premarin), anti-hypertensives (e.g. methyldopa), beta-
blockers (propranolol, atenolol, bisoprolol), cardiovascular
drugs (e.g. thiazide diuretics, digoxin), anti-Parkinsonism
drugs (e.g. L-dopa, benzhexol), neuroleptics and anti-
anxiety drugs (e.g. haloperodiol, risperidone, chloral
hydrate, benzodiazepines), NSAIDs (e.g. indomethacine,
naproxen, tramodol), anti-neoplastic medications (e.g.
tamoxifen, metrothexate), and others (e.g. cimetidine,
ranitidine).19
Data of socio-demographic characteristics and psycho-
social variables included age, gender, ethnicity, education,
housing type and size (which has been shown in national
census reports and numerous studies to be a more robust
indicator of socio-economic status than income), marital
status (whether widowed/divorced/separated), living
arrangement (whether living alone), whether having a
confidante, frequency of visits or telephone calls by family,
relatives or friends.Self-reported health status
Self-rated health status was assessed by a question, ‘In
general, would you say your health is excellent, very good,
good, fair, poor?’, which has been validated in numerous
studies to be highly predictive of health, functional and
mortality outcomes. The respondents were classified in two
categories of self-rated health (‘poor and fair’ or ‘good,
very good and excellent’).
Dyspnoea was assessed by a five-point dyspnoea scale
(modified Medical Research Council questionnaire),20 and
respondents were classified as having moderate to severe
dyspnoea (grade 2 or more) if they were breathless on
moderate exertion or worse.
Functional disability was assessed by the respondent’s
dependence in performing ten basic activities of daily living
(BADLs), including feeding, bathing, dressing, grooming,
bladder control, bowel control, toileting, transferring from
bed/chair, walking inside house, climbing stairs, derived
from the Barthel’s scale.21 Functional disability was defined
as needing at least some help in one or more BADLs.
The respondent’s quality of life was measured globally
using the Medical Outcomes Study 12-item Short Form
(SF-12),22 which provided two weighted summary scores e
Mental Health Component Summary (MCS) score for
mental health and functional status and Physical Health
Component Summary (PCS) score for physical health
and functional status. Higher scores on the PCS and MCS
indicate better health status and quality of life. Respondents
were classified as having worse quality of life by being in the
lowest tertile values of SF-12 PCS and MCS scores.
The respondent’s performance on self-management
tasks was assessed in relation to smoking and medications.
Respondents were classified on their smoking behaviour as
never smoking, stopped smoking and currently smoking.
Statistical analysis
The prevalence of depression, risk factors and outcomes of
respondents with and without COPD were compared by
using analysis of variance or chi-squared test, as appro-
priate. Multivariate binary or multinomial logistic regres-
sion analysis was used to estimate odds ratios (ORs) of
association, controlling for confounders such as socio-
demographic, psychosocial, co-morbidity, mood-altering
medications, health and functional status. This was also
performed in the subgroup of respondents with COPD to
estimate the ORs of association of depression with outcome
variables such as dyspnoea, BADL disability and poor or fair
self-reported health, and lowest tertiles of SF-12 PCS and
MCS scores. Statistical analyses were performed using SPSS
statistical software version 14.0 (SPSS Inc, Chicago Il). All
reported statistical tests were two-sided. A p value of
<0.05 was accepted as statistically significant.
Results
The majority of the 189 respondents with COPD had mild
obstructive airway disease, the remaining 43.9% having
moderate to severe obstruction (FEV1% predicted <80%).
Dyspnoea was assessed as moderate or severe in 32.8%.
Interestingly, only 25% reported that they were either past
or current smokers.
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a higher proportion who were depressed (22.8%) compared
to the 2213 respondents without COPD (12.4%, pZ 0.001),
Table 1. The crude OR was 2.08 (95% CI 1.44e2.98). The two
groups of respondents with and without COPD differed in
proportions of risk factors for depression, notably age,
housing size, education, widowed/divorced, number of
chronic medical conditions, use of potentially depresso-
genic drugs, IADL and BADL disability and self-reported
health status. The OR of association of depression with
COPD remained significantly elevated (OR, 1.86; 95% CI,Table 1 Prevalence of depression, risk factors and outcomes in
disease (COPD).
COPD
No, NZ
COPD severity
FEV1 80% predicted NA
FEV1< 80%, 50% predicted NA
FEV1< 50% predicted NA
Moderate to severe dyspnoea 6.4
BADL disability 5.5
Self-reported health fair or poor 31.8
SF-12 PCS scores
Lowest tertile 32.0
Middle tertile 33.4
Highest tertile 34.6
SF-12 MS scores
Lowest tertile 32.0
Middle tertile 35.1
Highest tertile 32.9
Depressive symptoms (GDS 5) 12.4
Female gender 63.2
Age, years
55e64 50.5
65e75 37.5
75 12.0
Housing size
1e3 room 27.3
4e5 room 42.7
Private apartments and landed housing 30.0
Education: <6 years 50.8
Widowed, Divorced. Separated 18.8
Lived alone 7.6
No confidante 5.0
Infrequent visits or telephone calls 14.7
Daily alcohol drinking 1.9
Past or current smoking
<20 cigarettes daily 10.8
20 cigarettes daily 4.6
Medical co-morbidities
None 7.5
1e2 60.0
3 or more 32.5
Potentially depressogenic medications 35.6
NA: Not applicable.
Figures shown in the table are percentages.1.25e2.75) after controlling for these potential confound-
ing variables (Table 2).
Among the 189 respondents with COPD (Table 3), those
who were depressed (NZ 43) had significantly greater
proportions of individuals who reported poor health and
functional status, compared to thosewhowerenotdepressed
(NZ 146). In multivariate analyses that controlled for COPD
severity, gender, age, housing size, education, smoking, co-
morbidity, BADL disability and dyspnoea as appropriate,
depression was significantly associated with BADL disability
(ORZ 2.89, pZ 0.049), poor or fair self-reported healthrespondents with and without chronic obstructive pulmonary
(FEV1/FVC< 70%)
2213 Yes, NZ 189 p
56.1
34.4
9.5 NA
32.8 <001
11.6 <0.001
43.9 0.001
44.4
37.6
18.0 <0.001
40.7
29.6
29.6 .04
22.8 0.001
64.6 0.71
37.6
44.4
18.0 <0.001
40.7
40.2
19.1 <0.001
70.9 <0.001
24.9 0.042
5.8 0.36
3.7 0.44
14.3 0.88
2.1 0.80
16.9
8.5 <0.001
4.2
52.9
42.9 0.008
46.0 0.004
Table 2 Odds ratios of association of depressive symp-
toms with COPD.
OR 95% CI
Crude 2.08 1.44 2.98
Adjusted for gender, age,
housing size, education,
being widowed, divorced,
separated, living alone,
having no confidante,
infrequent visits or telephone
calls by family or friends,
smoking, alcohol, smoking,
co-morbidity, potentially
depressogenic medications,
physical functional disability,
poor or fair self-reported health.
1.86 1.25 2.75
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pZ 0.041) andpoor SF-12MCS scores (ORZ 4.17,p< 0.001).
Depressed patients were more likely to report worse dysp-
noea (41.9% versus 30.1%) although the association in multi-
variate analysis was not statistically significant (pZ 0.13).
Depressed respondents also reported significantly no signifi-
cant differences in smoking status.
In multivariate analysis that controlled for other
covariates, the variables that were significantly associated
with depressive symptoms were increasing airflow
obstruction (FEV1 50e<80 and <50% versus 80 predicted,
ORZ 1.48, 1.64, p for trendZ 0.028), younger age (<65
and 65e74 versus 75, ORZ 1.40, 0.88, p for
trendZ 0.003), lower-end housing (ORZ 1.74, pZ 0.003),
living alone (ORZ 1.75, pZ 0.019), no confidante
(ORZ 2.31, pZ 0.001), poor self-rated health (ORZ 2.39,
pZ 0.001), moderate to severe dyspnoea (ORZ 1.53,
pZ 0.034), SF-12 PCS lowest tertile (ORZ 1.79, p< 0.001)
and SF-12 MCS lowest tertile (ORZ 5.21, p< 0.001).
Discussion
Rigorous systemic reviews indicate that the validity
and significance of the primary co-morbid association ofTable 3 Association of depressive symptoms with symptoms bu
with COPD (NZ 189).
Not depressed,
NZ 146 % (N)
Depressed,
NZ 43 % (N
Stopped smoking 15.1 (22) 9.3 (4)
Currently smoking 11.6 (17) 11.6 (5)
Moderate to severe dyspnoea 30.1 (44) 41.9 (18)
BADL disability 8.9 (13) 20.9 (9)
Fair or poor
self-reported health
37.7 (55) 65.1 (28)
SF-12 PCS lowest tertile 39.7 (58) 60.5 (26)
SF-12 MCS lowest tertile 33.6 (49) 65.1 (28)
1. COPD severity, gender, age, education, marital status, co-morbidit
2. Adjusted for COPD severity, gender, age, housing size, smoking, co
3. Adjusted for COPD severity, gender, age, housing size, smoking, co
4. Adjusted for COPD severity, gender, age, education, housing size,depression with COPD is unclear. The evidence from our
study strongly suggests a primary relationship between
COPD and depression that was independent of confounding
factors that are known to increase the risk of depression
that included psychosocial factors, smoking and alcohol,
multiple co-morbid illnesses, poor physical health and
functional disability, and medication use. Also our obser-
vation that COPD individuals with depression were more
likely to experience disability, worse health status and
quality of life and poor adherence to medication further
support the validity and significance of the co-morbid
association of depression with COPD.
Our results differ in important respects from previous
studies. Previous studies mostly controlled for a limited
number of confounding factors such as on age and sex,7,23e26
or education and social class.23,27 Also most COPD patients
have multiple co-morbid medical illnesses and use multiple
medications, and these are not taken into account in
previous studies. Our results showed that the presence of
multiple chronic illnesses and the use of medications that
reportedly could cause depression were not confounding
factors in the observed association with depression.
Previous studies of the relationship between depression
and COPD have involved highly selected groups of COPD
patients such as those on oxygen therapy or with acute
exacerbations.3,23 Selection bias from sampling subjects in
clinical settings and the narrow range of COPD severity thus
limit the generalizability of the results. The present study is
based on a large population cohort of community-living
older adults and included persons with COPD that reflected
a broad spectrum of disease severity.
The present study thus strongly suggests that the co-
morbid association of depression and COPD was related
uniquely to disease-specific psychobiological responses,
without the mediating effects of non-specific factors such
as poor physical health and functional status. We had
reported in an earlier study14 from the same cohort that
self-reports of asthma/COPD, next to gastro-intestinal
disorders, stood out among other chronic disorders in being
associated with depression. The present study supports our
earlier findings, but differs in using spirometric measures
that objectively identified a homogeneous group of persons
with COPD without asthma.rden, functional status and self-rated health in respondents
)
p Adjusted OR 95% CI p Model
1.44 0.37e5.55 0.60
0.62 0.89 0.24e3.32 0.87 1
0.15 1.80 0.85e3.83 0.13 2
0.031 2.89 1.01e8.38 0.049 3
<0.001 3.25 1.46e7.20 0.004 4
<0.001 2.35 1.04e5.35 0.041 4
<0.001 4.17 1.86e9.38 0.001 4
y, BADL disability.
-morbidity, BADL disability.
-morbidity and dyspnoea.
smoking, co-morbidity, BADL disability, dyspnoea.
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cussed.Our criteria are specific for caseswith chronic airflow
obstruction and were symptomatic, and consistent with
generally accepted clinical definitions of COPD. Spirometric
indices using pre- and post-bronchodilatation that is now
recommended for excluding reversible airways obstruction
due to bronchial asthma were not performed. We excluded
a large number (76) of symptomatic respondents with
a history of asthma diagnosis and anti-asthma medications.
As COPD is more often under-diagnosed and mislabeled as
asthma in the elderly, it was thus unlikely they would include
many asthma cases. Hence, misclassification errors are
small, and not likely to substantially bias the results. As
expected, COPD showed strong association with current
smoking (ORZ 2.28, 9% CI 1.41e3.70). We further restricted
our case definition of COPD to include only those who were
ever smokers (NZ 48), and observed similarly they had
a higher prevalence of depressive symptoms than non-COPD
respondents (22.9% versus 13.1%, pZ 0.048), although
because of small numbers, the association was of borderline
significance in multivariate analysis.
It may also be noted that apparently only 25% of cases
of COPD in our study were ever smokers. Considering that
usually at least two thirds of COPD cases are ever smokers
in Western population studies, this may be unexpected,
but there are plausible reasons for this. Unreported
smoking could partly account for this. The low prevalence
of smoking in the general population (14% overall, 27% in
men and 2.7% in women in 1998) is well documented in
Singapore.28 It is also possible that the effect of smoking
in increasing the risk and severity of COPD may be less
pronounced in Asian populations. Notwithstanding the
undisputed contribution of cigarette smoking, its relative
contribution to COPD may be reduced by its low preva-
lence and the contributions of other environmental and
infectious causes in Asian populations. Further research is
required.
There are limitations in the study. The Geriatric
Depression Scale which we used as a measure for depres-
sion is designed to detect the presence of clinically signif-
icant depressive symptoms, but is not tantamount to
a diagnosis of clinical depression. Among participants with
COPD, the estimation of effects was limited by the small
and unbalanced number of depressed and non-depressed
subjects. Hence, depressed COPD participants were not
significantly more likely to report worse dyspnoea.
However, we observed that, in agreement with previous
studies,6,23,29e31 depressed COPD individuals, compared to
non-depressed, were more likely to experience worse
physical impairment and quality of life. Other COPD
outcomes such as mortality and health resource use are
also relevant but were not studied. Finally, because the
cross-sectional design of the study precludes making firm
conclusions to be drawn about the temporal relationship,
further longitudinal studies are required.
The relationship between depression and COPD is
explained through complex causal mechanisms.32 Depres-
sion may contribute to the etiology and progression of COPD
and addictive smoking may be the common link. Mood
disorder in early life is a factor contributing to early
smoking and failure to quit, and the latter may persist after
the development of COPD in later life. Patients witha history of major depression are more likely to fail in
smoking cessation programs, and to fall into major
depression if they stop. Respiratory insufficiency in patients
with COPD is associated with progressive hypoxia that leads
to structural brain disease and impairs the function of
critical neurotransmitter systems involved in both cognition
and mood, resulting in neurocognitive deficits and day-to-
day functional impairment. Physical functional disability in
COPD patients itself promotes and perpetuates reactive
depression which can also be the cause of much problems
with medication adherence.
Depressive symptoms were present in 23% of our COPD
participants. The correlates and risk factors of depressive
symptoms in COPD subjects share much of the same
psychosocial etiology as depression in general, but signifi-
cantly include increased airflow obstruction and physical
health and functional impairment. Our results emphasize
the importance of identifying depression which is often
under-recognized and under-treated in patients with COPD.
Healthcare interventions should aim to improve physician
and patient recognition and treatment of depression.
Behavioural approaches to prevent, delay and treat
patients with COPD to improve patient outcomes merit
closer attention.
Conclusion
Depressive symptoms were associated with COPD indepen-
dent of known risk factors. In individuals with COPD,
depressive symptoms were associated with worse daily
functioning abilities, including medication adherence, and
health status and quality of life. Because depression is
often under-recognized, our findings underscore the
importance of treating depression to improve physical
functioning and quality of life in patients with COPD.
Acknowledgement
Funding: The study is supported by a research grant (No.
03/1/21/17/214) from the Biomedical Research Council,
Agency for Science, Technology and Research (ASTAR).
Conflict of interest statement
The authors declare no financial and personal relationships
with other people or organisations that could inappropri-
ately influence their work.
References
1. Murray CJ, Lopez AD. Global mortality, disability, and the
contribution of risk factors: global burden of disease study.
Lancet 1997;349(9063):1436 [PubMed -42].
2. Jemal A, Ward E, Hao Y, Thun M. Trends in the leading
causes of death in the United States, 1970-2002. JAMA 2005
Sep 14;294(10):1255e9.
3. Coultas DB, Edwards DW, Barnett B, Wludyka P. Predictors
of depressive symptoms in patients with COPD and health
impact. COPD 2007 Mar;4(1):23e8.
4. Schane RE, Woodruff PG, Dinno A, Covinsky KE, Walter LC.
Prevalence and risk factors for depressive symptoms
Co-morbid association of depression and COPD 901in persons with chronic obstructive pulmonary disease. J
Gen Intern Med 2008 Nov;23(11):1757e62 [Epub 2008
Aug 9].
5. Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive
symptoms and chronic obstructive pulmonary disease:
effect on mortality, hospital readmission, symptom burden,
functional status, and quality of life. Arch Intern Med 2007 Jan
8;167(1):60e7.
6. van Manen JG, Bindels PJE, Dekker FW, Yzermans CJ, van der
Zee JS, Schade´ E. Risk of depression in patients with
chronic obstructive pulmonary disease and its determinants.
Thorax 2002;57:412e6.
7. Yohannes AM, Roomi J, Baldwin RC, Connolly MJ. Depression
in elderly outpatients with disabling chronic obstructive
pulmonary disease. Age Ageing 1998;27:155e60.
8. van Ede L, Yzermans CJ, Brouwer HJ. Prevalence of depression
in patients with chronic obstructive pulmonary disease:
a systematic review. Thorax 1999 Aug;54(8):688e92.
9. Stewart AL, Greenfield S, Hays RD, Wells K, Rogers WH,
Berry SD, et al. Functional status and well being of patients
with chronic conditions: results from the medical outcomes
study. JAMA 1989;262:207e13.
10. Katon W, Sullivan MD. Depression and chronic medical illness.
J Clin Psychiatry 1990;51(Suppl. 6):3e11.
11. Wells KB, Rogers W, Burnam MA, Camp P. Course of depression
in patients with hypertension, myocardial infarction or insu-
lin-dependent diabetes. Am J Psychiatry 1993;150:632e8
[PubMed].
12. Fraser-Smith F, Lesperance F, Talagic M. Depression and
18-month prognosis after myocardial infarction. Circulation
1995;91:999e1005 [PubMed].
13. Ciechanowski PS, Katon WJ, Russo JE. Depression and dia-
betes: impact of depressive symptoms on adherence, function,
and costs. Arch Intern Med 2000;160:3278e85 [PubMed].
14. Niti M, Ng TP, Kua EH, Ho RC, Tan CH. Depression and
chronic medical illnesses in Asian older adults: the role of
subjective health and functional status. Int J Geriatr
Psychiatry 2007;22:1087e94.
15. Global Initiative for Chronic Obstructive Lung Disease. Global
strategy for the diagnosis, management and prevention of
chronic obstructive pulmonary disease. Executive summary.
NHLBI/WHO workshop report; 2001.
16. Yesavage JA, Brink TL. Development and validation of
a geriatric depression screening scale. A preliminary report.
J Psychiatr Res 1983;17:37e49.
17. Seikh JI, Yesavage JA. Geriatric depression scale (GDS):
recent evidence and development of a shorter version. Clin
Gerontol 1986;6:165e73.
18. Lim PP, Ng LL, Chiam PC, Ong PS, Ngui FT, Sahadevan S.
Validation and comparison of three brief depression scales inan elderly Chinese population. Int J Geriatr Psychiatry 2000;
15:824e30.
19. Patten SB, Barbui C. Drug-induced depression: a systematic
review to inform clinical practice. Psychother Psychosom 2004;
73(4):207e15.
20. Warley AR, Finnegan OC, Nicholson EM, Laszlo G. Grading
of dyspnoea and walking speed in cardiac disease and in chronic
airflow obstruction. Br J Dis Chest 1987 Oct;81(4):349e55.
21. Mahoney FI, Barthel DW. Functional evaluation: the Barthel
index. Md State Med J 1965;14:61e5.
22. Ware JE, Kosinski M, Keller SD. SF-12: how to score the SF-12
physical and mental health summary scales. 3rd ed. Lincoln,
Rhode Island: QualityMetric Inc., Bostom, Mass: The Health
Assessment Lab; 1998.
23. McSweeny AJ, Grant I, Heaton RK, et al. Life quality of patients
with chronic obstructive pulmonary disease. Arch Intern Med
1982;142:473e8.
24. Engstro¨m C, Persson L, Larsson S, et al. Functional status and
well being in chronic obstructive pulmonary disease with
regard to clinical parameters and smoking: a descriptive and
comparative study. Thorax 1996;51:825e30.
25. Gordon GH, Michiels TM, Mahutte CK, Light RW. Effect of
desipramine on control of ventilation and depression scores in
patients with severe chronic obstructive pulmonary disease.
Psychiatry Res 1985;15:25e32.
26. Isoaho R, Keistinen T, Laippala P, Kivela SL. Chronic obstructive
pulmonary disease and symptoms related to depression in
elderly persons. Psychol Rep 1995;76:287e97.
27. Prigatano GP, Wright EC, Levin D. Quality of life and its
predictors in patients with mild hypoxemia and chronic
obstructive pulmonary disease. Arch Intern Med 1984;
144:1613e9.
28. Ng TP, Tan WC, Niti M. Trends and ethnic differences in
COPD hospitalisation and mortality in Singapore. COPD 2004;
1:5e11.
29. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A
self-completed measure of health status for chronic airflow
limitation: the St George’s respiratory questionnaire. Am Rev
Respir Dis 1992;145:1321e7.
30. Felker B, Katon W, Hedrick SC, Rasmussen, McKnight JK,
McDonnell MB, et al. The association between depressive
symptoms and health status in patients with chronic pulmonary
disease. General Hospital Psychiatry 2001;23:56e61.
31. Gudmundsson G, Gislason T, Janson C, Lindberg E, Suppli
Ulrik C, Brondum E, et al. Depression, anxiety and health
status after hospitalisation for COPD: a multicentre study in
the Nordic countries. Respir Med 2006 Jan;100(1):87e93.
32. Borson S, Claypoole K, McDonald GJ. Depression and chronic
obstructive pulmonary disease: treatment trials. Semin Clin
Neuropsychiatry 1998 Apr;3(2):115e30.
